Jul 2, 2026 | Benchmarks, Bundled Reports, Employer Dashboard, MedBen Analytics, Reporting, Trend
Mid-2026 is the ideal time to review your first-half results and chart the course ahead. Rather than waiting for year-end surprises, MedBen Analytics delivers the foresight to make proactive, data-driven decisions now. Our employer dashboard converts raw claims data...
May 27, 2026 | Cancer, Claims, Client Report, GLP-1s, Heart disease, Specialty Drugs, Stop-Loss, Trend
A new Sun Life analysis shows high-cost claims continue to strain employer health plans. The annual High-Cost Claims and Injectable Drug Trends report identifies comorbid conditions, long inpatient stays, and injectable specialty drugs as primary drivers of claims...
Jul 10, 2025 | Cost Savings, Health care costs, Trend
Per Fierce Healthcare: “A new report from federal actuaries estimates national health spending will increase by 7.1% in 2025, with spending growth set to outpace growth in the U.S. gross domestic product.” Historically, MedBen clients have maintained a cost trend...
Oct 29, 2024 | Alternative Reimbursement Strategies, Chronic conditions, Client Report, Cost projections, Cost Savings, Direct-to-Employer Contracting, Drug costs, Fair market reimbursement, Forensic claims review, Health care costs, High-cost claims, MedBen Rx, MedBen WellLiving, Prescription, Rx Costs, Transparency, Trend, Wellness
Health care costs in the United States are projected to see their steepest rise in over a decade during 2025, with multiple industry analyses forecasting increases between 7% and 8% year-over-year (see table below). However, MedBen offers solutions that directly...
Aug 16, 2024 | Client Report, Reporting, Trend
From PwC’s “Behind the numbers 2025”: “PwC is projecting an 8% year-on-year medical cost trend in 2025 for the Group market and 7.5% for the Individual market, driven by inflationary pressure, prescription drug spending and behavioral health...
Feb 20, 2024 | Alternative Reimbursement Strategies, Announcements, Benchmarks, Benefits preservation, Fair market reimbursement, MedBen University, Pharmacogenomics, Precision medicine, Roundtables, Specialty Drugs, Trend
MedBen University (MBU) is in session, so mark your calendar! As we mentioned in the last e-briefs, MBU launched its 23rd season last month with the Benefits Advisory Conference for brokers… and this Spring, MBU will be conducting two employer roundtables:...
